Molecular genetics of X-linked charcot-marie-tooth disease

NeuroMolecular Medicine

Volumn 8, Issue 1-2, 2006, Pages 107-122

  Kleopa, Kleopas A ^a   Scherer, Steven S ^b  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CMT; Connexin32; Gap junctions; Myelin; Neuropathy; Oligodendrocytes; Schwann cells; X linked

Indexed keywords

CONNEXIN 32; GAP JUNCTION PROTEIN;

AREFLEXIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DISEASE SEVERITY; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GJB1 GENE; GOLGI COMPLEX; HEARING IMPAIRMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOTE; HOMEOSTASIS; HUMAN; MOLECULAR GENETICS; MUSCLE ATROPHY; MUSCLE WEAKNESS; MUTANT; MYELINATION; NERVE FIBER DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SCHWANN CELL; SYMPTOMATOLOGY; X CHROMOSOME LINKED DISORDER;

ANIMALIA;

EID: 33745246046     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:8:1-2:107     Document Type: Review

References (120)

1. Abel A., Bone L. J., Messing A., Scherer S. S., and Fischbeck K. F. (1999) Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol. 58, 702-710.
2. Abrams C. K., Bennett M. V. L., Verselis V. K., and Bargiello T. A. (2002) Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease. Proc. Natl. Acad. Sci. USA 99, 3980-3984.
3. Abrams C. K., Oh S., Ri Y., and Bargiello T. A. (2000) Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Rev. 32, 203-214.
4. Abrams C. K., Freidin M. M., Verselis V. K., Bennett M. V., and Bargiello T. A. (2001) Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease. Brain Res. 900, 9-25.
5. Allan W. (1939) Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch. Int. Med. 63, 1123-1131.
6. Altevogt B. M., Kleopa K. A., Postma F. R., Scherer S. S., and Paul D. L. (2002) Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J. Neurosci. 22, 6458-6470.
7. Altevogt B. M. and Paul D. L. (2004) Four classes of intercellular channels between glial cells in the CNS. J. Neurosci. 24, 4313-4323.
8. Anzini P., Neuberg D. H.-H., Schachner M., et al. (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32. J. Neurosci. 17, 4545-4561.
9. Bähr M., Andres F., Timmerman V., Nelis E., Van Broeckhoven C., and Dichgans J. (1999) Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin32 gene. J. Neurol. Neurosurg. Psychiatry 66, 202-206.
10. Balice-Gordon R. J., Bone L. J., and Scherer S. S. (1998) Functional gap junctions in the Schwann cell myelin sheath. J. Cell Biol. 142, 1095-1104.
11. Beckett J., Holden J. J. A., Simpson N. E., White B. N., and MacLeod P. M. (1986) Localization of X-linked dominant Charcot-Marie-Tooth disease (CMT2) to Xq13. J. Neurogenet. 3, 225-231.
12. Bergmann C., Schröder J. M., Rudnik-Schöneborn S., Zerres K., and Senderek J. (2001) A point mutation in the human connexin32 promoter P2 does not correlate with X-linked dominant Charcot-Marie-Tooth neuropathy in Germany. Mol. Brain Res. 88, 183-185.
13. Bergmann C., Zerres K., Rudnik-Schöneborn S., Eggermann T., Schröder J. M., and Senderek J. (2002) Allelic variants in the 5′ non-coding region of the connexin32 gene: possible pitfalls in the diagnosis of X linked Charcot-Marie-Tooth neuropathy (CMTX). J. Med. Genet. 39, e58.
14. Bergoffen J., Scherer S. S., Wang S., et al. (1993a) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262, 2039-2042.
15. Bergoffen J., Trofatter J., Pericak-Vance M. A., Haines J., Chance P. F., and Fischbeck K. H. (1993b) Linkage localization of X-linked Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 52, 312-318.
16. Birouk N., Le Guern E., Maisonobe T., et al. (1998) X-linked Charcot-Marie-Tooth disease with connexin 32 mutations - clinical and electrophysiological study. Neurology 50, 1074-1082.
17. Boerkoel C. F., Takashima H., Garcia C. A., et al. (2002) Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation. Ann. Neurol. 51, 190-201.
18. Bondurand N., Girard M., Pingault V., Lemort N., Dubourg O., and Goossens M. (2001) Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 10, 2783-2795.
19. Bruzzone R., White T. W., and Paul D. L. (1996) Connections with connexins: the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238, 1-27.
20. Bruzzone R., White T. W., Scherer S. S., Fischbeck K. H., and Paul D. L. (1994) Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 13, 1253-1260.
21. Buniello A., Montanaro D., Volinia S., Gasparini P., and Marigo V. (2004) An expression atlas of connexin genes in the mouse. Genomics 83, 812-820.
22. Campeanu E. and Morariu M. (1970) Les relations entre genotype et phenotype dans la maladie de Charcot-Marie-Tooth. Rev. Roum. Neurol. 7, 47-56.
23. Castro C., Gomez-Hernandez J. M., Silander K., and Barrio L. C. (1999) Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J. Neurosci. 19, 3752-3760.
24. Chandross K. J., Kessler J. A., Cohen R. I., et al. (1996) Altered connexin expression after peripheral nerve injury. Mol. Cell. Neurosci. 7, 501-518.
25. Cowie F. and Barrett A. (2001) Uneventful administration of cisplatin to a man with X-linked Charcot-marie-Tooth disease (CMT). Ann. Oncol. 12, 422.
26. de Weerdt C. J. (1978) Charcot-Marie-Tooth disease with sex-linked inheritance, linkage studies and abnormal serum alkaline phosphatase levels. Eur. Neurol. 17, 336-344.
27. Deschênes S. M., Walcott J. L., Wexler T. L., Scherer S. S., and Fischbeck K. H. (1997) Altered trafficking of mutant connexin32. J. Neurosci. 17, 9077-9084.
28. Dubourg O., Tardieu S., Birouk N., et al. (2001) Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain 124, 1958-1967.
29. Erwin W. G. (1944) A pedigree of sex-linked recessive peroneal atrophy. J. Hered. 35, 24-26.
30. Fain P. R., Barker D. F., and Chance P. F. (1994) Refined genetic mapping of X-linked Charcot-Marie-Tooth neuropathy. Am. J. Hum. Genet. 54, 229-235.
31. Fischbeck K. H., ar-Rushdi N., Pericak-Vance M., Rozear M., Roses A. D., and Fryns J. P. (1986) X-linked neuropathy: gene localization with DNA probes. Ann. Neurol. 20, 527-532.
32. Flagiello L., Cirigliano V., Strazzullo M., et al. (1998) Mutation in the nerve-specific 5′ non-coding region of Cx32 gene and absence of specific mRNA in a CMTX1 Italian family. Hum. Mutat. 12, 361-363.
33. Fryns J. P. and Van den Berghe H. (1980) Sex-linked recessive inheritance in Charcot-Marie-Tooth disease with partial clinical manifestation in female carriers. Hum. Genet. 55, 413-415.
34. Gal A., Mucke J., Theile H., Wieacker P. F., Ropers H. H., and Wienker T. F. (1985) X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum. Genet. 70, 38-42.
35. Goonewardena P., Welinhinda J., Anvret M., et al. (1988) A linkage study of the locus for X-linked Charcot-Marie-Tooth disease. Clin. Genet. 33, 435-440.
36. Gutierrez A., England J. D., Sumner A. J., et al. (2000) Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 23, 182-188.
37. Hahn A. F. (1993) Hereditary motor and sensory neuropathy: HMSN type II (neuronal type) and X-linked HMSN. Brain Pathol. 3, 147-155.
38. Hahn A. F., Ainsworth P. J., Bolton C. F., Bilbao J. M., and Vallat J. M. (2001) Pathological findings in the X-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol. 101, 129-139.
39. Hahn A. F., Ainsworth P. J., Naus C. C. G., Mao J., and Bolton C. F. (2000) Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve S39-S48.
40. Hahn A. F., Bolton C. F., White C. M., et al. (1999) Genotype/phenotype correlations in X-linked Charcot-Marie-Tooth disease. Ann. NY Acad. Sci. 883, 366-382.
41. Hahn A. F., Brown W. F., Koopman W. J., and Feasby T. E. (1990) X-linked dominant hereditary motor and sensory neuropathy. Brain 113, 1511-1525.
42. Haites N., Fairweather N., Clark C., Kelly K. F., Simpson S., and Johnston A. W. (1989) Linkage in a family with X-linked Charcot-Marie-Tooth disease. Clin. Genet. 35, 399-403.
43. Hanemann C. O., Bergmann C., Senderek J., Zerres K., and Sperfeld A. (2003) Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. Arch. Neurol. 60, 605-609.
44. Harding A. E. and Thomas P. K. (1980a) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103, 259-280.
45. Harding A. E. and Thomas P. K. (1980b) Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J. Med. Genet. 176, 329-336.
46. Hattori N., Yamamoto M., Yoshihara T., et al. (2003) Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 126, 134-151.
47. Heimler A., Friedman E., and Rosenthal A. D. (1978) Naevoid basal cell carcinoma and Charcot-Marie-Tooth disease. J. Med. Genet. 15, 288-291.
48. Herringham W. P. (1889) Muscular atrophy of the peroneal type affecting many members of a family. Brain 11, 230-236.
49. Houlden H., Girard M., Cockerell C., et al. (2004) Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction. Ann. Neurol. 56, 730-734.
50. Huang Y., Sirkowski E. E., Stickney J. T., and Scherer S. S. (2005) Prenylation-defective human connexin32 mutants cause a partial loss of function in myelinating Schwann cells. J. Neurosci. 25, 7111-7120
51. Hudder A. and Werner R. (2000) Analysis of a CMTX mutation reveals an essential IRES element in the connexin-32 gene. J. Biol. Chem. 275, 34,586-34,591.
52. Ionasescu V., Ionasescu R., and Searby C. (1996a) Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am. J. Med. Genet. 63, 486-491.
53. Ionasescu V. V., Burns T. L., Searby C., and Ionasescu R. (1988) X-linked dominant Charcot-Marie-Tooth neuropathy with 15 cases in a family: genetic linkage study. Muscle Nerve 11, 435-440.
54. Ionasescu V. V., Searby C., Ionasescu R., Neuhaus I. M., and Werner R. (1996b) Mutations of non-coding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 47, 541-544.
55. Ionasescu V. V., Trofatter J., Haines J. L., Summers A. M., Ionasescu R., and Searby C. (1992) X-linked recessive Charcot-Marie-Tooth neuropathy - clinical and genetic study. Muscle Nerve 15, 368-373.
56. Iselius L. and Grimby L. (1982) A family with Charcot-Marie-Tooth disease showing a probable X-linked incompletely dominant inheritance. Heriditas 97, 157, 158.
57. Kawakami H., Inoue K., Sakakihara I., and Nakamura S. (2002) Novel mutation in X-linked Charcot-Marie-Tooth disease associated with CNS impairment. Neurology 59, 923-926.
58. Kleopa K. A., Orthmann J. L., Enriquez A., Paul D. L., and Scherer S. S. (2004) Unique distribution of gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia 47, 346-357.
59. Kleopa K. A. and Scherer S. S. (2002) Inherited Neuropathies. Neurol. Clin. North Am. 20, 679-709.
60. Kleopa K. A., Yum S. W., and Scherer S. S. (2002) Cellular mechanisms of connexin32 mutations associated with CNS manifestations. J. Neurosci. Res. 68, 522-534.
61. Kobsar I., Berghoff M., Samsam M., et al. (2003) Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 126, 804-813.
62. Kobsar I., Maurer M., Ott T., and Martini R. (2002) Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32. Neurosci. Lett. 320, 17-20.
63. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., and Wegner M. (1998) Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237-250.
64. Kuntzer T., Dunand M., Schorderet D. F., Vallat J. M., Hahn A. F., and Bogousslavsky J. (2003) Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. J. Neurol. Sci. 207, 77-86.
65. Le Guern E., Ravise N., Gugenheim M., et al. (1994) Linkage analyses between dominant X-linked Charcot-Marie-Tooth disease, and 15 Xq11-Xq21 microsatellites in a new large family: three new markers are closely linked to the gene. Neuromusc. Disord. 4, 463-469.
66. Liang G. S. L., de Miguel M., Gomez-Hernandez J. M., et al. (2005) Severe neuropathy with leaky connexin32 hemichannels. Ann. Neurol. 57, 749-754.
67. Lin G. S., Glass J. D., Shumas S., Scherer S. S., and Fischbeck K. H. (1999) A unique mutation in connexin32 associated with severe, early onset CMTX in a heterozygous female. Ann. NY Acad. Sci. 883, 481-485.
68. Menichella D. M., Goodenough D. A., Sirkowski E., Scherer S. S., and Paul D. L. (2003) Connexins are critical for normal myelination in the CNS. J. Neurosci. 23, 5963-5973.
69. Mersiyanova I. V., Ismailov S. M., Polyakov A. V., et al. (2000) Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum. Mutat. 15, 340-347.
70. Mostacciuolo M. L., Muller E., Fardin P., et al. (1991) X-linked Charcot-Marie-Tooth disease: a linkage sudy in a large family by using 12 probes for the pericentromeric region. Hum. Genet. 87, 23-27.
71. Mostacciuolo M. L., Righetti E., Zortea M., et al. (2001) Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families. Hum. Mutat. 18, 32-41.
72. Nagy J. I., Ionescu A. V., Lynn B. D., and Rash J. E. (2003a) Connexin29 and connexin32 at oligodendrocyte and astrocyte gap junctions and in myelin of the mouse central nervous system. J. Comp. Neurol. 22, 356-370.
73. Nagy J. I., Ionescu A. V., Lynn B. D., and Rash J. E. (2003b) Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia 44, 205-218.
74. Nagy J. I. and Rash J. E. (2000) Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res. Rev. 32, 29-44.
75. Nakagawa M., Takashima H., Umehara F., et al. (2001) Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J. Neurol. Sci. 185, 31-36.
76. Neuhaus I. M., Bone L., Wang S., Ionasescu V., and Werner R. (1996) The human connexin32 gene is transcribed from two tissue-specific promoters. Biosci. Reports 16, 239-248.
77. Neuhaus I. M., Dahl G., and Werner R. (1995) Use of alternative promoters for tissue-specific expression of the gene coding for connexin32. Gene 158, 257-262.
78. Nicholson G. and Corbett A. (1996) Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain auditory evoked responses. J. Neurol. Neurosurg. Psychiatry 61, 43-46.
79. Nicholson G. and Nash J. (1993) Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 43, 2558-2564.
80. Nicholson G. A., Yeung L., and Corbett A. (1998) Efficient neurophysiological selection of X-linked Charcot-Marie-Tooth families. Neurology 51, 1412-1416.
81. Niewiadomski L. A. and Kelly T. E. (1996) X-linked Charcot-Marie-Tooth disease: molecular analysis of interfamilial variability. Am. J. Med. Genet. 66, 175-178.
82. Numakura C., Lin C., Ikegami T., Guldberg P., and Hayasaka K. (2002) Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Hum. Mutat. 20, 392-398.
83. Odermatt B., Wellershaus K., Wallraff A., et al. (2003) Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J. Neurosci. 23, 4549-4559.
84. Oh S., Ri Y., Bennett M. V. L., Trexler E. B., Verselis V. K., and Bargiello T. A. (1997) Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 19, 927-938.
85. Paulson H. L., Garbern J. Y., Hoban T. F., et al. (2002) Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann. Neurol. 52, 429-434.
86. Phillips L. H., Kelly T. E., Schnatterly P., and Parker D. (1985) Hereditary motor-sensory neuropathy (HMSN): possible X-linked dominant inheritance. Neurology 35, 498-502.
87. Rabadan-Diehl C., Dahl G., and Werner R. (1994) A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett. 351, 90-94.
88. Ressot C. and Bruzzone R. (2000) Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Rev. 32, 192-202.
89. Rouger H., Le Guern E., Birouk N., et al. (1997) Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: Characterization of 14 Cx32 mutations in 35 families. Hum. Mutat. 10, 443-450.
90. Rozear M. P., Pericak-Vance M. A., Fischbeck K., et al. (1987) Hereditary motor and sensory neuropathy, X-linked: a half century follow-up. Neurology 37, 1460-1465.
91. Sander S., Nicholson G. A., Ouvrier R. A., McLeod J. G., and Pollard J. D. (1998) Charcot-Marie-Tooth disease: histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1). Muscle Nerve 21, 217-225.
92. Sandri C., Van Buren J. M., and Akert K. (1982) Membrane morphology of the vertebrate nervous system. Prog. Brain Res. 46, 201-265.
93. Schelhaas H. J., Van Engelen B. G., Gabreels-Festen A. A., et al. (2002) Transient cerebral white matter lesions in a patient with connexin 32 missense mutation. Neurology. 59, 2007-2008.
94. Scherer S. S. and Kleopa K. A. (2005) X-linked Charcot-Marie-Tooth disease. In: Dyck P. J. and Thomas P. K. (eds), Peripheral Neuropathy, Philadelphia: Elsevier Saunders, pp. 1791-1804.
95. Scherer S. S. and Paul D. L. (2004) The connexin32 and connexin29 genes. In: Lazzarini R. A. (ed), Myelin Biology and Disorders, San Diego: Elsevier, pp. 599-608.
96. Scherer S. S., Bone L. J., Abel A., Deschênes S. M., Balice-Gordon R. J., and Fischbeck K. H. (1999) The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. In: Cardew G. (ed), Gap junction-mediated intercellular signalling in health and disease. Novartis Foundation Symposium 219. New York: John Wiley & Sons, pp. 175-185.
97. Scherer S. S., Deschênes S. M., Xu Y. -T., Grinspan J. B., Fischbeck K. H., and Paul D. L. (1995) Connexin32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 15, 8281-8294.
98. Scherer S. S., Xu Y. T., Messing A., Willecke K., Fischbeck K. H., and Jeng L. J. (2005) Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J. Neurosci. 25, 1550-1559.
99. Scherer S. S., Xu Y. -T., Nelles E., Fischbeck K., Willecke K., and Bone L. J. (1998) Connexin32-null mice develop a demyelinating peripheral neuropathy. Glia 24, 8-20.
100. Schnapp B. J. and Mugnaini E. (1978) Membrane architecture of myelinated fibers as seen by freeze-fracture. In: Waxman S. G. (ed), Physiology and pathobiology of axons, New York: Raven Press, pp. 83-123.
101. Senderek J., Bergmann C., Quasthoff S., Ramaekers V. T., and Schröder J. M. (1998) X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln). Acta Neuropathol. 95, 443-449.
102. Senderek J., Hermanns B., Bergmann C., et al. (1999) X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations. J. Neurol. Sci. 167, 90-101.
103. Silander K., Meretoja P., Juvonen V., et al. (1998) Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum. Mutat. 12, 59-68.
104. Sohl G., Gillen C., Bosse F., Gleichmann M., Muller H. W., and Willecke K. (1996) A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur. J. Cell Biol. 69, 267-275.
105. Söhl G., Theis M., Hallas G., et al. (2001) A new alternatively spliced transcript of the mouse connexin32 gene is expressed in embryonic stem cells, oocytes, and liver. Exp. Cell Res. 266, 177-186.
106. Swift M. R. and Horowitz S. L. (1969) Familial jaw cysts in Charcot-Marie-Tooth disease. J. Med. Genet. 6, 193-195.
107. Tabaraud F., Lagrange E., Sindou P., Vandenberghe A., Levy N., and Vallat J. M. (1999) Demyelinating X-linked Charcot-Marie-Tooth disease: unusual electrophysiological findings. Muscle Nerve 22, 1442-1447.
108. Taylor R. A., Simon E. M., Marks H. G., and Scherer S. S. (2003) The CNS phenotype of X-linked Charcot-Marie-Tooth disease: more than a peripheral problem. Neurology 61, 1475-1478.
109. Tetzlaff W. (1982) Tight junction contact events and temporary gap junctions in the sciatic nerve fibres of the chicken during Wallerian degeneration and subsequent regeneration. J. Neurocytol. 11, 839-858.
110. Timmerman V., de Jonghe P., Spoelders P., et al. (1996) Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 46, 1311-1318.
111. Uhlenberg B., Schuelke M., Ruschendorf F., et al. (2004) Mutations in the gene encoding gap junction protein alpha 12 (Connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am. J. Hum. Genet. 75, 251-260.
112. Unger V. M., Kumar N. M., Gilula N. B., and Yeager M. (1999) Three-dimensional structure of a recombinant gap junction membrane channel. Science 283, 1176-1180.
113. Vital A., Ferrer X., Lagueny A., et al. (2001) Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations. J. Peripher. Nerv. Syst. 6, 79-84.
114. Vondracek P., Seeman P., Hermanova M., and Fajkusova L. (2005) X-linked Charcot-Marie-Tooth disease: phenotypic expression of a novel mutation Ile127Ser in the GJB1 (connexin 32) gene. Muscle Nerve 31, 252-255.
115. Wang H. L., Wu T., Chang W. T., et al. (2000) Point mutation associated with X-linked dominant Charcot-Marie-Tooth disease impairs the P2 promoter activity of human connexin-32 gene. Mol. Brain Res. 78, 146-153.
116. Warner L. E., Mancias P., Butler I. J., et al. (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18, 382-384.
117. White T. W. and Paul D. L. (1999) Genetic diseases and gene knockouts reveal diverse connexin functions. Annu. Rev. Physiol. 61, 283-310.
118. Willecke K., Eiberger J., Degen J., et al. (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 383, 725-737.
119. Woratz G. (1964) Neurale Muskelatrophie mit Dominantem X-Chromosomalem Erbgang. Berlin: Akademie-Verlag.
120. Yum S. W., Kleopa K. A., Shumas S., and Scherer S. S. (2002) Diverse trafficking abnormalities of Connexin32 mutants causing CMTX. Neurobiol. Dis. 11, 43-52.